{"id":"NCT00251693","sponsor":"Takeda","briefTitle":"Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis","officialTitle":"A Phase 3 Study to Evaluate the Efficacy and Safety of TAK-390MR (60 mg Once- Daily [QD] and 90 mg QD) and an Active Comparator, Lansoprazole (30 mg QD) on Healing of Erosive Esophagitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-12","primaryCompletion":"2007-01","completion":"2007-01","firstPosted":"2005-11-10","resultsPosted":"2009-03-23","lastUpdate":"2012-02-03"},"enrollment":2038,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Esophagitis, Reflux","Esophagitis, Peptic"],"interventions":[{"type":"DRUG","name":"Dexlansoprazole MR","otherNames":["TAK-390MR","Kapidex","Dexilant"]},{"type":"DRUG","name":"Dexlansoprazole MR","otherNames":["TAK-390MR","Kapidex","Dexilant"]},{"type":"DRUG","name":"Lansoprazole","otherNames":["Prevacid","AG-1749"]}],"arms":[{"label":"Dexlansoprazole MR 60 mg QD","type":"EXPERIMENTAL"},{"label":"Dexlansoprazole MR 90 mg QD","type":"EXPERIMENTAL"},{"label":"Lansoprazole 30 mg QD","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to assess the efficacy and safety of 8 weeks of once-daily (QD) treatment with dexlansoprazole modified release (MR) 60 mg or 90 mg or lansoprazole 30 mg in healing subjects with endoscopically proven erosive esophagitis.","primaryOutcome":{"measure":"Percentage of Subjects With Complete Healing of Erosive Esophagitis (EE) by Week 8 as Assessed by Endoscopy - Crude Rate Analysis.","timeFrame":"8 Weeks","effectByArm":[{"arm":"Dexlansoprazole MR 60 mg QD","deltaMin":85.3,"sd":null},{"arm":"Dexlansoprazole MR 90 mg QD","deltaMin":85.8,"sd":null},{"arm":"Lansoprazole 30 mg QD","deltaMin":79,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"0.004"},{"comp":"OG001 vs OG002","p":"0.001"},{"comp":"OG000 vs OG001","p":"0.727"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":9},"locations":{"siteCount":140,"countries":["United States","Australia","Bulgaria","Canada","Czechia","Germany","Hungary","India","Latvia","Lithuania","New Zealand","Peru","Poland","Slovakia","South Africa"]},"refs":{"pmids":["19183157","19735233","20195905","21129076","24118079","23451835"],"seeAlso":["http://general.takedapharm.com/content/file/pi.pdf?applicationcode=9efb34b3-fb69-4190-a2be-a90b8cb94e25&filetypecode=DEXILANTPI"]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":680},"commonTop":["Diarrhoea (Excl Infective)","Gastrointestinal and Abdominal Pains (Excl Oral and Throat)","Upper Respiratory Tract Infections"]}}